Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Chagas Disease

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Chagas Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Cabanelas, A; Coelho, FS; Fragoso, SP; Gonçalves, IC; Lopes, AH; Martins-Duarte, ES; Moreira, ICF; Oliveira, MM; Pascutti, PG; Torres, PHM; Vieira, DP1
Carvalho, I; Kawano, DF1
Alviano, CS; Alviano, DS; Atella, GC; Folly, E; Gomes, MT; Lopes, AH; Silva-Filho, FC; Zimmermann, LT1
Barcelos, L; Klein, A; Machado, FS; Santana, GC; Silva, JS; Talvani, A; Teixeira, MM1
Aliberti, JC; Gazzinelli, RT; Machado, FS; Silva, JS; Teixeira, MM1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Chagas Disease

ArticleYear
Targeting Trypanosoma cruzi platelet-activating factor receptors: scope for the development of novel drugs to treat Chagas Disease.
    Mini reviews in medicinal chemistry, 2013, Volume: 13, Issue:7

    Topics: Acrylates; Animals; Chagas Disease; Humans; Models, Biological; Molecular Structure; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Trypanosoma cruzi

2013

Other Studies

4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Chagas Disease

ArticleYear
A novel receptor for platelet-activating factor and lysophosphatidylcholine in Trypanosoma cruzi.
    Molecular microbiology, 2021, Volume: 116, Issue:3

    Topics: Amino Acid Sequence; Animals; Cell Differentiation; Chagas Disease; Gene Knockout Techniques; Host-Parasite Interactions; Humans; Lysophosphatidylcholines; Macrophages; Mice; Molecular Docking Simulation; Phylogeny; Platelet Activating Factor; Protein Conformation; Protozoan Proteins; Receptors, Adiponectin; Receptors, Progesterone; Trypanosoma cruzi

2021
Effects of platelet-activating factor on the interaction of Trypanosoma cruzi with Rhodnius prolixus.
    Parasitology research, 2011, Volume: 108, Issue:6

    Topics: Animals; Azepines; Chagas Disease; Host-Parasite Interactions; N-Acetylneuraminic Acid; Neuraminidase; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rhodnius; Triazoles; Trypanosoma cruzi

2011
Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection.
    Infection and immunity, 2002, Volume: 70, Issue:8

    Topics: Animals; Benzopyrans; Carboxylic Acids; Cells, Cultured; Chagas Disease; Disease Models, Animal; Female; Immunity, Innate; Interferon-gamma; Leukotriene B4; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Nitric Oxide; Platelet Activating Factor; Receptors, Leukotriene B4; Time Factors; Trypanosoma cruzi; Tumor Necrosis Factor-alpha

2002
Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice.
    Infection and immunity, 1999, Volume: 67, Issue:6

    Topics: Animals; Cell Line; Cells, Cultured; Chagas Disease; Disease Models, Animal; Female; Immunity, Innate; Macaca mulatta; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Nitric Oxide; Parasitemia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Trypanocidal Agents; Trypanosoma cruzi

1999